Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit

Genes Dev. 2010 Oct 15;24(20):2276-81. doi: 10.1101/gad.1937710.

Abstract

Cyclic AMP (cAMP) is a ubiquitous second messenger that regulates a variety of biological processes. The magnitude and duration of cAMP expression are regulated by both production and hydrolysis. Melanocyte-stimulating hormone (MSH) plays a crucial role in pigment cell differentiation via cAMP-regulated expression of the master transcription factor MITF. We report the identification of phosphodiesterase 4D3 as a direct target of the MSH/cAMP/MITF pathway. This creates a negative feedback loop that induces refractoriness to chronic stimulation of the cAMP pathway in melanocytes. This homeostatic pathway highlights a potent mechanism controlling melanocyte differentiation that may be amenable to pharmacologic manipulation for skin cancer prevention.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Cell Differentiation*
  • Cell Line, Tumor
  • Cells, Cultured
  • Colforsin / pharmacology
  • Cyclic AMP / metabolism
  • Cyclic Nucleotide Phosphodiesterases, Type 4 / genetics
  • Cyclic Nucleotide Phosphodiesterases, Type 4 / metabolism*
  • Feedback, Physiological
  • Homeostasis
  • Humans
  • Immunoblotting
  • Infant, Newborn
  • Male
  • Melanins / metabolism
  • Melanocyte-Stimulating Hormones / genetics
  • Melanocyte-Stimulating Hormones / metabolism
  • Melanocytes / cytology
  • Melanocytes / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Microphthalmia-Associated Transcription Factor / genetics
  • Microphthalmia-Associated Transcription Factor / metabolism*
  • Phosphodiesterase 4 Inhibitors
  • Phosphodiesterase Inhibitors / pharmacology
  • Protein Binding
  • RNA Interference
  • Rolipram / pharmacology
  • Signal Transduction
  • Skin / drug effects
  • Skin / metabolism

Substances

  • Melanins
  • Microphthalmia-Associated Transcription Factor
  • Phosphodiesterase 4 Inhibitors
  • Phosphodiesterase Inhibitors
  • Colforsin
  • Melanocyte-Stimulating Hormones
  • Cyclic AMP
  • Cyclic Nucleotide Phosphodiesterases, Type 4
  • Rolipram